标题
Current and Emerging Drug Treatment Options for Alzheimerʼs Disease
作者
关键词
-
出版物
DRUGS
Volume 71, Issue 15, Pages 2031-2065
出版商
Springer Nature
发表日期
2011-10-05
DOI
10.2165/11595870-000000000-00000
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline
- (2013) Parminder Raina et al. ANNALS OF INTERNAL MEDICINE
- 2011 Alzheimer’s disease facts and figures
- (2011) Alzheimers & Dementia
- Revision of the criteria for Alzheimer's disease: A symposium
- (2011) Steven T. DeKosky et al. Alzheimers & Dementia
- Tramiprosate in mild-to-moderate Alzheimer’s disease – a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)
- (2011) Paul S. Aisen et al. Archives of Medical Science
- Genetics of Alzheimer's disease: new evidences for an old hypothesis?
- (2011) Jean-Charles Lambert et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Plasma β-amyloid peptides in canine aging and cognitive dysfunction as a model of Alzheimer's disease
- (2011) Ángela González-Martínez et al. EXPERIMENTAL GERONTOLOGY
- Drug delivery strategies for Alzheimer's disease treatment
- (2011) Antonio Di Stefano et al. Expert Opinion on Drug Delivery
- Memantine in dementia: a review of the current evidence
- (2011) Nathan Herrmann et al. EXPERT OPINION ON PHARMACOTHERAPY
- Use of Florbetapir-PET for Imaging β-Amyloid Pathology
- (2011) Christopher M. Clark JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A phase II trial of huperzine A in mild to moderate Alzheimer disease
- (2011) M. S. Rafii et al. NEUROLOGY
- A Single Ascending Dose Study of Bapineuzumab in Patients With Alzheimer Disease
- (2010) Ronald S. Black et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Solanezumab was safe and well-tolerated for Asian patients with mild-to-moderate Alzheimer's disease in a multicenter, randomized, open-label, multi-dose study
- (2010) Taro Goto et al. Alzheimers & Dementia
- A Randomized Pilot Clinical Trial of the Safety of Pioglitazone in Treatment of Patients With Alzheimer Disease
- (2010) David S. Geldmacher et al. ARCHIVES OF NEUROLOGY
- A Meta-Analysis of Cytokines in Alzheimer's Disease
- (2010) Walter Swardfager et al. BIOLOGICAL PSYCHIATRY
- Safety and Changes in Plasma and Cerebrospinal Fluid Amyloid β After a Single Administration of an Amyloid β Monoclonal Antibody in Subjects With Alzheimer Disease
- (2010) Eric R. Siemers et al. CLINICAL NEUROPHARMACOLOGY
- Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study
- (2010) Martin R. Farlow et al. CLINICAL THERAPEUTICS
- The Pharmacoeconomics of Cognitive Enhancers in Moderate to Severe Alzheimerʼs Disease
- (2010) Jaclyn Cappell et al. CNS DRUGS
- Drug Profile: Transdermal Rivastigmine Patch in the Treatment of Alzheimer Disease
- (2010) Murat Emre et al. CNS Neuroscience & Therapeutics
- High PIB Retention in Alzheimers Disease is an Early Event with Complex Relationship with CSF Biomarkers and Functional Parameters
- (2010) A. Forsberg et al. Current Alzheimer Research
- Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer’s Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study
- (2010) Michael Gold et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Memantine ER, a once-daily formulation for the treatment of Alzheimer's disease
- (2010) Nazem Bassil et al. EXPERT OPINION ON PHARMACOTHERAPY
- Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer Disease
- (2010) Joseph F. Quinn et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Metabolic Syndrome and Risk of Dementia in Older Adults
- (2010) Paola Forti et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
- (2010) Juha O Rinne et al. LANCET NEUROLOGY
- Alzheimer's disease: clinical trials and drug development
- (2010) Francesca Mangialasche et al. LANCET NEUROLOGY
- Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
- (2010) Harald Hampel et al. NATURE REVIEWS DRUG DISCOVERY
- The clinical use of structural MRI in Alzheimer disease
- (2010) Giovanni B. Frisoni et al. Nature Reviews Neurology
- Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe
- (2010) H. H. Feldman et al. NEUROLOGY
- Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: neuroprotective effects of Cerebrolysin
- (2009) Kiren Ubhi et al. ACTA NEUROPATHOLOGICA
- NIC5-15 as a treatment for Alzheimer's: Safety, pharmacokinetics and clinical variables
- (2009) Hillel Grossman et al. Alzheimers & Dementia
- Oral amyloid anti-aggregating agent ELND005 is measurable in CSF and brain of healthy adult men
- (2009) Pamela Garzone et al. Alzheimers & Dementia
- Aβ variability and effect of gamma secretase inhibition on cerebrospinal fluid levels of Aβ in healthy volunteers
- (2009) Holly Soares et al. Alzheimers & Dementia
- The ADCS valproate neuroprotection trial: Primary efficacy and safety results
- (2009) Pierre N. Tariot et al. Alzheimers & Dementia
- GSI-953 is a potent APP-selective gamma-secretase inhibitor for the treatment of Alzheimer's disease
- (2009) Steven Jacobsen et al. Alzheimers & Dementia
- Review: Donepezil in Severe Alzheimer's Disease
- (2009) Bengt Winblad American Journal of Alzheimers Disease and Other Dementias
- Brief Psychosocial Therapy for the Treatment of Agitation in Alzheimer Disease (The CALM-AD Trial)
- (2009) Clive Ballard et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- A γ-secretase inhibitor decreases amyloid-β production in the central nervous system
- (2009) Randall J. Bateman et al. ANNALS OF NEUROLOGY
- Syncope and Its Consequences in Patients With Dementia Receiving Cholinesterase Inhibitors
- (2009) Sudeep S. Gill et al. ARCHIVES OF INTERNAL MEDICINE
- Methylene blue and Alzheimer's disease
- (2009) Murat Oz et al. BIOCHEMICAL PHARMACOLOGY
- Nicotinic Receptor-Mediated Neuroprotection in Neurodegenerative Disease Models
- (2009) Shun Shimohama BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Meta-Analysis of Alzheimer's Disease Risk with Obesity, Diabetes, and Related Disorders
- (2009) Louis A. Profenno et al. BIOLOGICAL PSYCHIATRY
- Rivastigmine Transdermal Patch Skin Tolerability
- (2009) Jeffrey L. Cummings et al. CLINICAL DRUG INVESTIGATION
- The Role of Peroxisome Proliferator-Activated Receptor-γ (PPARγ) in Alzheimer’s Disease
- (2009) Qingguang Jiang et al. CNS DRUGS
- Novel Regimens and Delivery Systems in the Pharmacological Treatment of Alzheimerʼs Disease
- (2009) Nazem Bassil et al. CNS DRUGS
- Natural Non-Trasgenic Animal Models for Research in Alzheimers Disease
- (2009) Manuel Sarasa et al. Current Alzheimer Research
- Safety and Tolerability of Donepezil, Rivastigmine and Galantamine for Patients with Alzheimer’s Disease: Systematic Review of the ‘Real-World’ Evidence
- (2009) I.A. Lockhart et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Memantine in Moderately-Severe-to-Severe Alzheimerʼs Disease
- (2009) Francesca Clerici et al. DRUGS & AGING
- Cerebrolysin
- (2009) Greg L. Plosker et al. DRUGS & AGING
- Memantine versus donepezil in mild to moderate Alzheimer’s disease: a randomized trial with magnetic resonance spectroscopy
- (2009) P. J. Modrego et al. EUROPEAN JOURNAL OF NEUROLOGY
- Cholesterol-modifying strategies for Alzheimer’s disease
- (2009) Alina Solomon et al. Expert Review of Neurotherapeutics
- Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer DiseaseA Randomized Controlled Trial
- (2009) Robert C. Green JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Can Lithium or Valproate Untie Tangles in Alzheimer's Disease?
- (2009) Pierre N. Tariot et al. JOURNAL OF CLINICAL PSYCHIATRY
- Lithium Trial in Alzheimer's Disease
- (2009) Harald Hampel et al. JOURNAL OF CLINICAL PSYCHIATRY
- Green Tea (-)-Epigallocatechin-3-Gallate Inhibits β-Amyloid-Induced Cognitive Dysfunction through Modification of Secretase Activity via Inhibition of ERK and NF-κB Pathways in Mice
- (2009) Jae Woong Lee et al. JOURNAL OF NUTRITION
- Domain-specific cognitive effects of tramiprosate in patients with mild to moderate Alzheimer’s disease: ADAS-cog subscale results from the Alphase study
- (2009) D. Saumier et al. Journal of Nutrition Health & Aging
- Development of AFFITOPE vaccines for Alzheimer’s disease (AD) — From concept to clinical testing
- (2009) A. Schneeberger et al. Journal of Nutrition Health & Aging
- A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
- (2009) S. Salloway et al. NEUROLOGY
- Cholinesterase Inhibitors and Hospitalization for Bradycardia: A Population-Based Study
- (2009) Laura Y. Park-Wyllie et al. PLOS MEDICINE
- P4-346: Safety, tolerability and biomarker effects of an Abeta monoclonal antibody administered to patients with Alzheimer's disease
- (2008) Eric R. Siemers et al. Alzheimers & Dementia
- P4-351: Effects of uninterrrupted intravenous immunoglobulin treatment of Alzheimer's disease for nine months
- (2008) Diamanto Tsakanikas et al. Alzheimers & Dementia
- O3-04-07: Tau aggregation inhibitor (TAI) therapy with rember™ arrests disease progression in mild and moderate Alzheimer's disease over 50 weeks
- (2008) Claude M. Wischik et al. Alzheimers & Dementia
- Phase 2 Safety Trial Targeting Amyloid β Production With a γ-Secretase Inhibitor in Alzheimer Disease
- (2008) Adam S. Fleisher et al. ARCHIVES OF NEUROLOGY
- Green tea epigallocatechin-3-gallate (EGCG) reduces β-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice
- (2008) Kavon Rezai-Zadeh et al. BRAIN RESEARCH
- Peroxisome Proliferator-Activated Receptor-γ-Mediated Positive Energy Balance in the Rat Is Associated with Reduced Sympathetic Drive to Adipose Tissues and Thyroid Status
- (2008) William T. Festuccia et al. ENDOCRINOLOGY
- Emerging and potential therapies for Alzheimer's disease
- (2008) Heledd H Griffiths et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Reassessing the amyloid cascade hypothesis of Alzheimer's disease
- (2008) Sanjay W. Pimplikar INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Etazolate, a neuroprotective drug linking GABAAreceptor pharmacology to amyloid precursor protein processing
- (2008) Maryline Marcade et al. JOURNAL OF NEUROCHEMISTRY
- Volumetric MRI and cognitive measures in Alzheimer disease
- (2008) B. H. Ridha et al. JOURNAL OF NEUROLOGY
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
- Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study
- (2008) Rachelle S Doody et al. LANCET
- Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial
- (2008) Lars Lannfelt et al. LANCET NEUROLOGY
- Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial
- (2008) Gordon K Wilcock et al. LANCET NEUROLOGY
- Evaluation of Dimebon in cellular model of Huntington's disease
- (2008) Jun Wu et al. Molecular Neurodegeneration
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
- (2008) Ganesh M Shankar et al. NATURE MEDICINE
- 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease
- (2008) Norman R. Relkin et al. NEUROBIOLOGY OF AGING
- Alzheimer’s disease risk variants show association with cerebrospinal fluid amyloid beta
- (2008) John S. K. Kauwe et al. NEUROGENETICS
- Statins, incident Alzheimer disease, change in cognitive function, and neuropathology
- (2008) Z. Arvanitakis et al. NEUROLOGY
- Tau-based treatment strategies in neurodegenerative diseases
- (2008) Anja Schneider et al. Neurotherapeutics
- PPARγ agonists as therapeutics for the treatment of Alzheimer’s disease
- (2008) Gary Landreth et al. Neurotherapeutics
- No Effect of One-Year Treatment with Indomethacin on Alzheimer's Disease Progression: A Randomized Controlled Trial
- (2008) Daniëlle de Jong et al. PLoS One
- The amyloid -peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae
- (2008) C. A. Hansson Petersen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease
- (2008) P. Hemachandra Reddy et al. TRENDS IN MOLECULAR MEDICINE
- Efficacy of Memantine on Behavioral and Psychological Symptoms Related to Dementia: A Systematic Meta-Analysis
- (2007) Ian D Maidment et al. ANNALS OF PHARMACOTHERAPY
- Galantamine in Alzheimer’s disease
- (2007) George Razay et al. Expert Review of Neurotherapeutics
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started